FDA guidelines consider amyloid reduction 'reasonably likely' to predict Alzheimer's benefit
FDA guidelines consider amyloid reduction 'reasonably likely' to predict Alzheimer's benefit
gmasson
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *
